» Articles » PMID: 39390390

Depth of Invasion and Extranodal Extension: the Influential Factors to Predict Survival Rate of Patients with Oral Tongue Squamous Cell Carcinoma

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2024 Oct 10
PMID 39390390
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancer staging is essential in determining patients' prognoses and designing the appropriate treatment strategy. American Joint Committee on Cancer has released the latest version of the staging system for tongue SCC. However, it is interesting to know whether this change in staging and the addition of depth of invasion (DOI) and the extra-nodal extension (ENE) have any influence on patients' prognosis.

Methods: In this retrospective cohort study, the pathology records of patients with tongue SCC who underwent surgery at the Pathology Department of Cancer Institute Hospital, 2017-2021, were collected by referring to the hospital information system. Then the rate of change of pT, pN, and overall stage were assessed based on American Joint Committee on Cancer 7th and 8th editions.

Results: The records of 204 patients were included in the final analysis. Significant changes in the staging system 2021 resulted in upstaging 64 patients (31.4%) in the overall stage, 91 patients (44.6%) in pT, and 30 patients (14.7%) in pN. The survival of upstaged patients was inferior compared to those without upstaging. However, this was not statistically significant for tumor and overall upstaging in the univariate analysis, while those with upstaged pN had significantly shorter survival. In the multivariate analysis, pT upstage also significantly impacted survival.

Conclusion: This study showed the importance of pathology reports based on the latest edition of the American Joint Committee on Cancer, the accuracy in examining factors such as depth of invasion and extra-nodal extension.

Citing Articles

HSP27/IL-6 axis promotes OSCC chemoresistance, invasion and migration by orchestrating macrophages via a positive feedback loop.

Qi Y, Cao J, Jiang M, Lin Y, Li W, Li B Cell Biol Toxicol. 2025; 41(1):36.

PMID: 39873845 PMC: 11775009. DOI: 10.1007/s10565-024-09983-1.

References
1.
Kano S, Sakashita T, Tsushima N, Mizumachi T, Nakazono A, Suzuki T . Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma. Int J Clin Oncol. 2018; 23(5):844-850. DOI: 10.1007/s10147-018-1276-5. View

2.
Ng J, Iyer N, Tan M, Edgren G . Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study. Head Neck. 2016; 39(2):297-304. DOI: 10.1002/hed.24589. View

3.
Matos L, Dedivitis R, Kulcsar M, de Mello E, Alves V, Cernea C . External validation of the AJCC Cancer Staging Manual, 8th edition, in an independent cohort of oral cancer patients. Oral Oncol. 2017; 71:47-53. DOI: 10.1016/j.oraloncology.2017.05.020. View

4.
Kato M, Baek C, Chaturvedi P, Gallagher R, Kowalski L, Leemans C . Update on oral and oropharyngeal cancer staging - International perspectives. World J Otorhinolaryngol Head Neck Surg. 2020; 6(1):66-75. PMC: 7221211. DOI: 10.1016/j.wjorl.2019.06.001. View

5.
Mascitti M, Zhurakivska K, Togni L, Caponio V, Almangush A, Balercia P . Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma. Histopathology. 2020; 77(5):810-822. DOI: 10.1111/his.14202. View